CD14 [D7A2T] Antibody – 154Sm

Catalog: 715402

Clone: D7A2T

Isotype: Rabbit IgG

Reactivity: Human*

Application: MIBI-FFPE
Storage: Supplied in antibody stabilizer with 0.05% sodium azide. Store at 4°C

CD14-IHC-staining-FFPE-human-melanoma

IHC: CD14 staining of FFPE human melanoma

CD14-Ionpath-MIBI-staining-FFPE-human-melanoma

MIBI: CD14 staining (cyan) of FFPE human melanoma, costained with dsDNA (magenta)

CD14-IHC-staining-FFPE-human-thymus

IHC: CD14 staining of FFPE human thymus

CD14-Ionpath-MIBI-staining-FFPE-human-thymus

MIBI: CD14 staining (cyan) of FFPE human thymus, costained with dsDNA (magenta)

Background: CD14 is highly expressed on monocytes and macrophages and at much lower levels on neutrophils and some dendritic cells. Non-classical monocytes have lower expression of CD14 than classical monocytes and express CD16. CD14 recognizes pathogen-associated molecular patterns (PAMPs) and is a coreceptor for lipopolysaccharide (LPS), expressed by Gram-negative bacteria.

Validation: Each lot of conjugated antibody is quality control tested by staining tissue following the MIBI Staining Protocol optimized for the applicable tissue format with subsequent MIBIscope analysis of stained tissue microarray using the appropriate positive and negative tissue field of views. 

Recommended Usage: Human FFPE: 1 ug/mL dilution.
For optimal results, the antibody should be titrated for each desired application.

MIBI technology: Learn more about MIBI Technology, a multiplex IHC technology with unmatched sensitivity and true subcellular resolution.

References
Ziegler-Heitbrock, L. Blood Monocytes and Their Subsets: Established Features and Open Questions. Front Immunol. 2015; 17(6):423.

* Conjugate tested on human tissue.

Contact Us

<p style="text-align: center; margin-top: 2em;">Let us know how we can help you.</p>


    Immuno-oncology/CancerNeuroscienceInfectious DiseaseImmunologyStem CellOther

    255

    Please contact me. I understand that I can choose to unsubscribe at any time by e-mailing marketing@ionpath.com.

    X
    Contact Us

    We are using cookies on our website

    Please confirm, if you accept our tracking cookies. You can also decline the tracking and continue to visit our website without any data sent to third-party services.